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Background: Internalizing mental disorders (IMDs) among HIV-positive (HIV+) children 
and adolescents are associated with poor disease outcomes, such as faster HIV disease 
progression. Although it has been suggested that the development of IMDs is moderated 
by interaction of stressful life events and vulnerability factors, the underlying etiology is 
largely unknown. Serotonin transporter gene [solute carrier family 6 member A4 (SLC6A4)] 
and human tryptophan hydroxylase 2 gene (TPH2) polymorphisms have been implicated 
in the development of IMDs. This study investigated the association between acute stress 
and IMDs, and moderation by chronic stress and genetic variants in SLC6A4 and TPH2.
Hypothesis: Acute stress acts through genetic and environmental vulnerability factors 
to increase the risk of developing IMDs.
Methods: Polymorphisms in SLC6A4 (5-HTTLPR, rs25531, 5-HTTLPR-rs25531, and 
STin2 VNTR) and TPH2 (rs1843809, rs1386494, rs4570625, and rs34517220) were 
genotyped in 368 HIV+ children and adolescents (aged 5–17 years) with any internalizing 
mental disorder (depression, anxiety disorders, or posttraumatic stress disorder), and 368 
age- and sex-matched controls, who were also HIV+. Chronic and acute stress categories 
were derived by hierarchical cluster analysis. Logistic regression analysis was used to 
assess the independent moderating effect of chronic stress and each selected 
polymorphism on the association between acute stress and IMDs.
Results: We observed a statistically significant association between severe acute stress 
and IMDs (p = 0.001). Children and adolescents who experienced severe acute stress 
were twice as likely to develop IMDs, compared to children and adolescents who 
experienced mild acute stress (p = 0.001). Chronic stress interacted with severe acute 
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INTRODUCTION
HIV-positive (HIV+) children and adolescents suffer a 
considerable burden of internalizing mental disorders (IMDs; 
Mellins et  al., 2012; Nachman et  al., 2012; Kinyanda et  al., 
2019). IMDs are characterized by quiet, internal distress (Tandon 
et  al., 2011) and include depressive and anxiety disorders, as 
well as posttraumatic stress disorder (PTSD; American Psychiatric 
Association, 2013). IMDs among people living with HIV/AIDS 
have generally been associated negative outcomes of more rapid 
HIV disease progression (Ironson et  al., 2005; Chida and 
Vedhara, 2009), poor adherence to medication (Springer et  al., 
2012; Kinyanda et  al., 2018), risky sexual behavior (Springer 
et  al., 2012; Kinyanda et  al., 2018), and poor linkages to care 
(Bhatia et  al., 2011).
Internalizing mental disorders are complex disorders with 
gene-environment interactions contributing to their etiology 
(Musci et  al., 2019), where a number of genes play a role 
with each gene contributing a small effect (Plomin and Davis, 
2009; Assary et  al., 2018). The role of psychosocial factors 
and their interaction with biological mechanisms in the etiology 
of IMDs is still poorly understood. HIV+ children and adolescents 
experience various chronic life stressors such as awareness of 
their HIV-status, increased levels of stigma and poorer parental 
mental health (Betancourt et  al., 2014). As chronic stressors 
are reported to be  risk factors for IMDs (Adelman et al., 2014; 
Robles et  al., 2014; Revenson et  al., 2016), chronic stressors 
likely contribute to the etiology of IMDs among HIV+ children 
and adolescents (Boyes and Cluver, 2015; Lwidiko et al., 2018).
Internalizing mental disorders are heritable (Smoller, 2016): 
twin studies have estimated a genetic heritability of 35% for 
depression (Otte et  al., 2016) and 30-50% for PTSD (Smoller, 
2016). In addition, a meta-analysis of family and twin studies 
estimated a genetic heritability of 31.6% for generalized anxiety 
disorder (GAD; Hettema et  al., 2001). A more recent genome-
wide association study (GWAS) of monozygotic and dizygotic 
female twins has estimated a genetic heritability of 42% for 
GAD (Davies et al., 2015). Despite being heritable, the underlying 
etiology of IMDs is largely unknown although dysregulation 
in serotonergic transmission has been implicated in depression 
among adults living with HIV (Hammoud et  al., 2010).
Serotonergic pathways in the central nervous system is 
important in regulating mood and anxiety (Olivier, 2015). 
After an impulse is fired and serotonin (5-HT) is released 
into the synaptic cleft, 5-HT re-uptake reduces the activity of 
the serotonergic neurons, preparing the neuron for a new 
discharge (Artigas, 2013a,b; Olivier, 2015). Encoded by the 
serotonin transporter gene [solute carrier family 6 member 4 
(SLC6A4)], the serotonin transporter (5-HTT) influences 
serotonergic transmission by regulating the duration of serotonin 
in the synaptic cleft (Rudnick, 2006; Kristensen et  al., 2011). 
5-HTT is a target for selective serotonin re-uptake inhibitors 
(SSRIs) that competitively block substrate binding and thereby 
prolong neurotransmitter action at the synapse (Kristensen 
et  al., 2011; Cipriani et  al., 2018). Tryptophan hydroxylase 2 
(TPH2) catalyzes the rate-limiting step in 5-HT biosynthesis 
(Walther et al., 2003; Carkaci-Salli et al., 2006) and is expressed 
exclusively in the brainstem (Kennedy et  al., 2012), an area 
which is the major locus of serotonin-producing neurons 
(Kennedy et  al., 2012). Long-term treatment with the SSRI 
fluoxetine has been found to be  associated with concurrent 
upregulation of TPH2 messenger ribonucleic acid (mRNA) 
expression and alleviation of depressive symptoms (Shishkina 
et  al., 2007), suggesting that low TPH2 gene expression could 
represent a dysregulation corrected by fluoxetine.
SLC6A4 is located on chromosome 17 at position 17q11 
(National Center for Biotechnology Information, 2021a). The 
serotonin transporter-linked polymorphic region (5-HTTLPR) 
within the promoter region of SLC6A4 has been implicated 
in depression (Clarke et  al., 2010; Wang et  al., 2016), anxiety-
related traits (Munafò et  al., 2009b), and PTSD (Xie et  al. 
2009). 5-HTTLPR variants comprise either 14 (short, S-allele) 
or 16 (long, L-allele) copies of a 22–23 base pair (bp) imperfect 
repeat (Heils et al., 1996). In vitro studies show that the L-allele 
has two to three times higher basal transcriptional activity 
compared to the S-allele (Lesch et  al., 1996; Philibert et  al., 
2008). In proximity to 5-HTTLPR is an A to G single nucleotide 
polymorphism (SNP), rs25531 which has been reported to 
alter expression of the SLC6A4 by creating a functional AP2 
transcription-factor binding site (Hu et  al., 2006; Ehli et  al., 
2012). The rs25531 G-allele has been associated with reduced 
transporter gene expression (Hu et  al., 2006; Ehli et  al., 2012). 
This SNP, when analyzed in combination with 5-HTTLPR, 
results in L-A and L-G haplotypes. The L-G haplotype has 
been associated with lower SLC6A4 expression levels compared 
to the L-A haplotype (Hu et  al., 2006; Lipsky et  al., 2009). 
stress to increase the risk of IMDs (p = 0.033). Acute stress was found to interact with 
5-HTTLPR-rs25531 S-A-S-A haplotype to increase the risk for IMDs among Ugandan 
HIV+ children and adolescents (p = 0.049). We  found no evidence for a combined 
interaction of acute stress, chronic stress, and 5-HTTLPR-rs25531 on IMDs.
Conclusion: The odds of having an internalizing mental disorder (IMD) were higher among 
HIV+ children and adolescents who experienced severe acute stress compared to HIV+ 
children and adolescents who experienced mild acute stress. Chronic stress and 
5-HTTLPR-rs25531 independently moderated the association between acute stress and IMDs.
Keywords: internalizing mental disorders, acute stress, serotonin transporter gene, 5-HTTLPR-rs25531, chronic 
stress, HIV+ children and adolescents, Uganda
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However, some studies have found no effect of the L-G haplotype 
on SLC6A4 expression (Martin et al., 2007; Philibert et al., 2008).
A variable number of tandem repeats (VNTR) polymorphism 
also occurs within the second intron (STin2) of SLC6A4. The 
polymorphism consists of multiple repeat copies of a 16–17  bp 
element (Battersby et al., 1996; Furlong et al., 1998). Three alleles 
have been reported (National Center for Biotechnology 
Information, 2021b), containing 9 (STin2.9), 10 (STin2.10), and 
12 (STin2.12) copies of the repeat. The alleles have been associated 
with differential expression of SLC6A4, as STin2.9 has been found 
to be  associated with increased SLC6A4 expression, and an 
increasing number of repeats associated with reduced reporter 
gene expression in rat neonate prefrontal cortical cultures (Ali 
et  al., 2010). The STin2 VNTR polymorphism has also been 
found to interact with 5-HTTLPR to regulate expression of 
SLC6A4, with the combination of the 5-HTTLPR S-allele and 
either STin2.10 or STin2.12 associated with increased expression, 
as compared to STin2.9 whose combination with 5-HTTLPR 
S-allele directed expression levels comparable to the 5-HTTLPR 
S-allele alone (Ali et al., 2010; Haddley et al., 2012). The STin2.9 
allele has been associated with anxiety in patients with self-
harming behaviors (Evans et al., 2013), STin2.10 has been associated 
with both anxiety and PTSD (Evans, Li and Whipple, 2013; 
Xiao et  al., 2019) and the STin2.12 allele has been associated 
with depression, neuroticism, and suicide (Lopez de Lara et al., 2007; 
O’Gara et  al., 2008; Kalungi et  al., 2017).
The TPH2 gene is located on chromosome 12 at position 
12q21.1. Located within intron 5 (rs1843809 and rs1386494), 
and within the promoter region (rs4570625), rs1843809, 
rs1386494, and rs4570625 have been linked to depression 
(Zill et  al., 2004; Anttila et  al., 2009; Gao et  al., 2012). 
Located within the TPH2 transcription factor binding site, 
rs34517220 SNP has been reported to modulate TPH2 expression 
by altering binding sites for foxa1 and foxa2 transcription 
factors (Pristerà et  al., 2015). Also, foxa2 plays a role in 
establishing progenitor domains for serotonergic neuron 
precursors in the ventral hindbrain and in activating transcription 
factors required for the terminal differentiation of serotonergic 
neurons (Jacob et  al., 2007). Therefore, rs34517220-driven 
variation in foxa2 binding may have important effects on the 
development of neural serotonergic systems.
The diathesis-stress hypothesis of neuropsychiatric disorders 
postulates that a lower stress threshold is required for psychiatric 
disease to occur in individuals who harbor certain vulnerability 
factors, which may be  genetic and/or acquired (Monroe and 
Simons, 1991; Silberg et al., 2001; Caspi et al., 2003; Figure 1). 
Stress is a common environmental risk factor for a number 
of mental disorders, including depression, anxiety, and PTSD 
(de Kloet et  al., 2005; Popoli et  al., 2011), and it is currently 
accepted that gene-environment interactions underlie the etiology 
of many, if not all, IMDs (Caspi and Moffitt, 2006; Willis and 
Brock, 2018; Jawahar et  al., 2019).
In the context of the diathesis-stress hypothesis, with acute 
stress representing the exposure variable in a sample of HIV+ 
children and adolescents, we  investigated polymorphisms in 
SLC6A4 (5-HTTLPR, rs25531, and STin2 VNTR) and TPH2 
(rs1843809, rs1386494, rs4570625, and rs34517220) as genetic 
vulnerability factors and chronic stress as an acquired vulnerability 
factor for IMDs. Our a priori selection of these polymorphisms 
was based on their associations with IMDs (5-HTTLPR, STin2 
VNTR, TPH2 rs1843809, rs1386494, rs4570625, and rs34517220) 
and regulation of SLC6A4 (STin2 VNTR, rs25531).
FIGURE 1 | The conceptual framework is adapted from the diathesis-stress model for depression (Monroe and Simons, 1991). The aim of the present study was 
to investigate the association between acute stress and IMDs (A). We postulated that acute stress would interact with vulnerability factors [B; genetic (yellow block), 
acquired (pink block), or both (blue block)] to increase the risk for IMDs. SLC6A4, serotonin transporter gene; TPH2, tryptophan hydroxylase 2 gene.
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MATERIALS AND METHODS
Study Design
This case-control study was nested within a study which 
investigated mental health among HIV infected children and 
adolescents in Kampala and Masaka, Uganda (CHAKA study). 
Characteristics of the study participants and the study design 
for the CHAKA study are detailed elsewhere (Mpango et al., 2017; 
Kinyanda et  al., 2019).
All study participants were of Bagandan ethnicity, the largest 
ethnic group in Uganda, and were thus expected to be genetically 
similar since relatively modest genetic differentiation has been 
observed among populations representing the major 
sub-populations in sub-Saharan Africa (Gurdasani et al., 2015). 
All participants in the present study were HIV+ children and 
adolescents (aged 5–17  years) of black African (Ugandan) 
ancestry (Kinyanda et  al., 2019). Cases (n  =  368) were defined 
as participants who had any depressive disorder [depression 
or dysthymia (persistent depressive disorder)] or any anxiety 
disorder (GAD, separation anxiety disorder, social anxiety 
disorder, panic disorder, and agoraphobia) or PTSD. Controls 
(n  =  368) were age-, site-, socio-economic status (SES)-, and 
sex-matched without any psychiatric disorder. Genomic DNA 
was extracted from an archived cell pellet sample for 
each participant.
Clinical Assessments
Children and assented adolescents, as well as their caregivers, 
were interviewed using a structured questionnaire. The 
questionnaire included, among others, socio-demographic 
characteristics (sex, study site, age, caregiver level of education, 
and SES) and modules on different psychiatric disorders from 
the DSM-5 referenced Children and Adolescent Symptom 
Inventory 5 (CASI-5; caregiver reported; Gadow and Sprafkin, 
2013) and the Youth Inventory-4R (YI-4R; youth reported; 
Gadow and Sprafkin, 1999). The CASI-5 and YI-4R list the 
symptoms of a wide range of psychiatric disorders including 
major depressive disorder, GAD, PTSD, and attention-deficit/
hyperactivity disorder, among others. Individual CASI-5 items 
are rated on a 4-point frequency of occurrence scale ranging 
from never (0) to very often (3). Though there are several 
CASI-5 scoring algorithms, in the present study, we  used 
symptom count cut-off scores that reflect the prerequisite 
number of symptoms for a clinical diagnosis. About 4  ml of 
blood was withdrawn from each study participant by venipuncture 
into an EDTA vacutainer and was stored at −80°C pending 
DNA extraction for the genetics analyses.
Inclusion and Exclusion Criteria
Inclusion criteria were: (i) HIV-infected outpatients, registered 
with an HIV clinic at any of the study sites; (ii) aged between 
5 and 17  years at the time of enrolment; (iii) conversant in 
English or Luganda, the language into which research assessment 
tools were translated; and (iv) able to provide written informed 
consent (caregiver) and assent (adolescents). Exclusion criteria 
were: (i) seriously ill and (ii) being unable to understand 
study procedures.
Ethical Considerations
The study was conducted in compliance with the Code of Ethics 
of the World Medical Association (Declaration of Helsinki). 
The CHAKA study obtained ethical and scientific clearance from 
the Uganda Virus Research Institute’s Science and Ethical 
Committee (# GC/127/15/06/459) and the Uganda National 
Council of Science and Technology (# HS 1601). The study 
reported here obtained approval from the Higher Degrees 
Research and Ethics Committee of the School of Biomedical 
Sciences, Makerere University (# SBS 421) and the Health 
Research Ethics Committee of Stellenbosch University 
(# S17/09/179). All caregivers provided informed consent for 
their children/adolescents to participate in the study and for a 
blood specimen to be  drawn from them (child/adolescent) for 
genetics analyses. Adolescents further provided informed assent 
to participate in the study. Study participants who were diagnosed 
with significant psychiatric problems were referred to mental 
health units at Entebbe and Masaka government hospitals.
Selection of Cases and Controls
The procedure for selection of cases and controls has been 
previously described (Kalungi et  al., 2021). Briefly, all cases 
were stratified by site, sex, age category, and SES, resulting in 
a total of 36 strata. In each stratum, the number of cases was 
ascertained (e.g., for males in site 1 in the youngest age category 
and the lowest SES group there were nine cases). An equal 
number of controls were then randomly sampled from the 
stratum concerned, thus the controls were matched to the 
cases by site, sex, age, and SES.
DNA Extraction
DNA was extracted from whole blood using the QiAmp Mini 
DNA Extraction Kit according to manufacturer’s instructions 
(Qiagen GmbH, Germany).
Selection of Variants Within the Serotonin 
Transporter and Tryptophan Hydroxylase 2 
Genes
The selection of variants was based on their role in regulating 
gene expression or association with any of the IMDs. Also, because 
the Bantu group of people in East Africa have been reported 
to genetically cluster together as per principal components analysis 
(unpublished results from NeuroGAP data), a minor allele frequency 
cut-off of at least 0.1 was set for each selected SNP based on 
the Luhya, a population that belongs to same Bantu group as 
the population of the present study. The minor allele frequency 
data were obtained from an online genomic project (Clarke et al., 
2017). Supplementary Table S1 summarizes the biological data 
based on for selection for each of the SLC6A4 and TPH2 variants.
SLC6A4 Genotyping
All polymerase chain reactions (PCR) for SLC6A4 polymorphisms 
were performed in a GeneAmp PCR System 9700 (Perkin 
Elmer Biosystems, Foster City, CA, United States). Amplification 
reactions were carried out in 25 μl reaction volumes containing: 
DNA template, 200  μM dNTP (Kapa Biosystems, Cape Town, 
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South  Africa), 5  μl of 10X Taq DNA polymerase buffer (Kapa 
Biosystems), 1.0  mM magnesium chloride (Kapa Biosystems), 
0.625  units (U) Taq DNA polymerase (Kapa Biosystems), and 
0.5 μM of each primer (Integrated DNA Technologies, Coralville, 
IA, United  States), with bi-distilled water.
The 5-HTTLPR, 5-HTTLPR-rs25531, and STin2 VNTR 
polymorphisms were genotyped following a procedure described 
by Kalungi et  al. (2017). Fragment sizes revealed by PCR were 
confirmed by restriction fragment length analysis on the ABI 
prism. Expected fragment sizes of the alleles at the 
5-HTTLPR-rs25531 locus were as follows: S-A  =  281  bp, 
L-A = 325 bp and S-G-L-G = 151 bp, resulting into the following 
genotypes: S-A-S-A  =  281  bp; L-A-L-A  =  325  bp; S-G-S-G, 
L-G-L-G, L-G-S-G  =  151  bp; L-G-S-A  =  151  +  281  bp and 
L-A-S-G, L-A-L-G  =  325  +  151  bp. Expected fragment sizes 
of the alleles at the STin2 VNTR locus were as follows: 9-repeat 
(STin2.9) = 250 bp, 10-repeat (STin2.10) = 265 bp and 12-repeat 
(STin2.12)  =  300  bp, resulting in the following genotypes: 
9/9  =  250  bp, 9/10  =  250  +  265  bp, 9/12  =  250  +  300  bp, 
10/10  =  265  bp, 10/12  =  265  +  300  bp, and 12/12  =  300  bp.
Determining Genotypes for Selected 
Single Nucleotide Polymorphims in 
Tryptophan Hydroxylase 2 Gene
DNA samples were quantified and sent to LGC laboratory 
(LGC, Middlesex, United  Kingdom) for automated SNP 
genotyping using the kompetitive allele-specific PCR (KASP) 
assay. Genotypes were determined for TPH2 rs1843809, 
rs1386494, rs4570625, and rs34517220. However, none of these 
genotypes were validated using an alternate method.
Haplotype Analyses
We used Haploview version 4.2 (Barrett, 2009) to analyze 
linkage disequillibrium (LD) in SLC6A4 and TPH2. SLC6A4 
analyses included 5-HTTLPR, rs25531, and STin2 VNTR 
polymorphisms. 5-HTTLPR and STin2 VNTR alleles were coded 
as dummy variables, i.e., S  =  1, L  =  2, and STin2.10  =  1 and 
STin2.12  =  2. As very few participants carried the STin2.9 
allele (n  =  6), they were excluded from the analysis.
TPH2 analyses included the three single nucleotide polymorphisms 
(SNPs) genotyped. Participants with more than 50% missing 
genotypes were excluded from the analysis, yielding data from 
692 participants for each of the SLC6A4 and TPH2 analyses. None 
of the investigated TPH2 polymorphisms were in LD (D’  <  0.8), 
while SLC6A4 5-HTTLPR and rs25531 were in LD (D’  >  0.8) 
(Supplementary Figures S1, S2).
Generation of Acute and Chronic Stress 
Class Categories
Social disadvantage variables were grouped into an index of 
acute and chronic stress. Caregiver mental state (assessed as 
psychological distress using the Self-report Questionnaire-20; 
Beusenberg et  al., 1994), child-caregiver relationship [assessed 
as child-caregiver interactions, using data on how often the 
caregiver (i) beats, (ii) insults, (iii) spanks, or (iv) yells at the 
child/adolescent] and HIV symptoms were grouped together 
to constitute “acute stress” and orphanhood, study site (urban 
vs. rural), and caregiver level of education as variables constituting 
“chronic stress.” Variables were scored on a disadvantage scale 
where, for example, double orphanhood carried a higher chronic 
stress score vs. single orphanhood or not orphaned; food 
availability: not enough food carried a higher chronic stress 
score vs. enough food; study site: urban carried a higher chronic 
stress score than rural; and caregiver level of education: no 
formal education carried a higher chronic stress scores than 
primary and primary a higher stress score than secondary, 
etc. Hierarchical cluster analysis using Statistica 13.5 software 
(TIBCO, CA, United  States), Euclidian distance, as distance 
measure and Ward’s method for clustering (Ward, 1963), was 
used to generate the different cut-off points for each acute 
and chronic stress class, respectively.
The acute stress index ranged from 0 to 2.46, with a normal 
distribution, while the chronic stress index ranged from 0 to 
3.75, with a normal distribution as well. A total of three classes 
were generated for each type of stress by the hierarchical cluster 
analysis, i.e., mild, moderate, and severe. For acute stress, the 
mild class had an acute stress score of less than 0.362, the 
moderate class a score of 0.362–0.622, while the severe class 
a score of greater than 0.622. For chronic stress, the mild 
class had a chronic stress score of less than 1.375, the moderate 
class a score of 1.375–2.375, while the severe class a score of 
greater than 2.375.
Power of the Study
Using Stata 15 (StataCorp, TX, United States) software, we did 
a post hoc power calculation. Given a case-control ratio of 
1:1, and assuming a zero correlation of exposure between 
cases and controls, a probability of 0.5 of exposure among 
controls at a 0.05 significance level, and an expected odds 
ratio of at least 1.8 for IMDs under severe acute stress, 
we  needed 188 cases to achieve a power of 80% (Lachin, 
1992). Our study comprising 368 cases was, therefore, adequately 
powered to address the main aim. Assuming similar assumptions, 
our interaction analyses achieved a power of 87.5%.
Statistical Methods
Statistical analyses were conducted using Stata 15 (StataCorp, 
TX, United  States). Socio-demographic characteristics were 
compared between cases and controls. SES was generated from 
a scale of nine household items owned (car, motorcycle, 
refrigerator, electricity, bicycle, radio, telephone, cupboard, and 
flask) as previously described (Kalungi et  al., 2019). A t-test 
was used to compare the distribution of cluster of differentiation 
4 (CD4) counts between cases and controls. We  computed 
95% confidence intervals and statistical significance was set at 
a value of p less than or equal to 0.05.
Genotype distributions were compared between cases and 
controls. Likelihood-ratio tests were used to test genotypes for 
the Hardy-Weinberg equilibrium (HWE) in both cases and 
controls. Logistic regression was used to assess the relationship 
between TPH2 rs1843809 and IMDs (equation for the model 
was Y  =  β0  +  β1X1, where Y  =  IMDs, β0  =  constant, 
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X1  =  rs1843809, and β1  =  coefficient for rs1843809). Logistic 
regression models were used to assess the relationship between 
acute stress and IMDs (equation for the model was 
Y  =  β0  +  β1X1, where Y  =  IMDs, β0  =  constant, X1  =  acute 
stress, and β1  =  coefficient for acute stress).
The moderating effect of chronic stress on the association 
between acute stress and IMDs was assessed by comparing 
logistic regression models of the association between acute 
stress and IMDs with and without chronic stress. Interactions 
between acute stress and chronic stress were tested using a 
likelihood ratio test (equation for the model was 
Y = β0 + β1X1 + β2X2 + β3X1X2, where Y = IMDs, β0 = constant, 
X1  =  acute stress, X2  =  chronic stress and β1–β3 are the 
coefficients for acute stress, chronic stress, and the interaction 
term, respectively).
The moderating effect of each genotype on the association 
between acute stress and IMDs was assessed by comparing 
logistic regression models of the association between acute 
stress and IMDs with and without the polymorphism 
controlling for chronic stress. Interactions between acute 
stress and each of the polymorphism were tested using a 
likelihood ratio test, controlling for chronic stress (equation 
for the model was Y  =  β0  +  β1X1  +  β2X2  +  β3X3  +  β4X1X2, 
where Y  =  IMDs, β0  =  constant, X1  =  acute stress, 
X2  =  polymorphism/SNP, X3  =  chronic stress and β1–β4 are 
the coefficients for acute stress, the polymorphism/SNP, 
chronic stress, and the interaction, respectively). These 
interaction models were performed on all the explanatory 
variables even without observing significant main effects, 
in order to rule out the possibility of cross-over interaction, 
where significant interactions may be  observed for 
non-significant main effects (Widaman et al., 2012). Three-way 
interactions of acute stress, chronic stress, and any selected 
polymorphism on IMDs were not assessed as the two-way 
models were better than the three-way models, based on 
goodness of fit test, Arkaike informatics criteria, and the 
Bayesian information criterion. The 95% confidence intervals 
were calculated for all analyses.
RESULTS
Socio-demographic factors were similarly distributed between 
cases and controls as shown in Table  1.
The HWE p-values among cases and controls for each 
polymorphism are shown in Table  2. None of the genotype 
frequencies deviated significantly from HWE among controls 
except for rs1386494, which was thus omitted from further 
analysis. For SLC6A4 polymorphisms, 5-HTTLPR was in LD 
with rs25531 (D’  >  0.8) (Supplementary Figure S1), while 
for TPH2 SNPs, none of the selected polymorphisms were in 
LD (D’  <  0.8) (Supplementary Figure S2).
The association between each investigated polymorphism 
and IMDs is shown in Table  2. There was a protective effect 
against IMDs in participants with TPH2 rs1843809 TG and 
TT genotypes compared with participants with the GG 
genotype (Table  3).
Table  4 shows the association between acute stress and 
IMDs. A significant association was observed between acute 
stress and being an IMD case. Table  5 shows the independent 
effect of chronic stress and SLC6A4 5-HTTLPR-rs25531 haplotype 
on the association seen in Table  4 (between acute stress and 
IMDs). The independent effect of all other polymorphisms on 
the association between acute stress and IMDs are shown in 
Supplementary Table S2.
Apart from the SLC6A4 5-HTTLPR-rs25531 haplotype 
(Table  5), we  found no significant interactions between acute 
stress and any polymorphism on IMDs (Supplementary Table S2). 
A significant interaction between acute and chronic stress 
(p  =  0.033) and acute stress and 5-HTTLPR-rs25531 S-A-S-A 
haplotype (p  =  0.049) was observed on IMDs (Table  5). The 
odds of having an IMD were 4.3 times higher among participants 
under both severe acute stress and severe chronic stress, compared 
to those under mild acute stress and mild chronic stress 
(Table  5). The odds for being a case of an IMD were 14.8 
times higher in participants with the S-A-S-A haplotype who 
experienced acute stress as compared to participants with the 
L-A-L-A haplotype who experienced mild acute stress. Similarly, 
the odds of having an IMD were 11.95 times higher in S-A-
S-A participants with severe acute stress compared to L-A-L-A 
participants with mild stress (Table  5).
DISCUSSION
This study investigated the association between acute stress 
and IMDs, and whether this association was moderated by 
chronic stress or selected genetic variants in SLC6A4 and TPH2. 
To our knowledge, this is the first sub-Saharan African study 
to investigate these interactions among HIV+ children 
TABLE 1 | Distribution of socio-demographic factors in cases and controls.
Variable (n, %) Case n (%) Control n (%) p
Sex 0.111
 Male (342, 46.5%) 160 (43.6) 182 (49.5)
 Female (393, 53.5%) 207 (56.4) 186 (50.5)
Site 0.941
 Urban (415, 56.4%) 208 (56.5) 207 (56.3)
 Rural (321, 43.6%) 160 (43.5) 161 (43.7)
Age 0.374
 7-11 years (389, 55.9%) 202 (57.6) 187 (54.2)
 12-17 years (307, 44.1%) 149 (42.4) 158 (45.8)
Education level 0.371
 No formal education 
(13, 1.8%)
9 (2.5) 4 (1.1)
 Primary (648, 88.4%) 323 (88.0) 325 (88.8)
 Secondary (72, 9.8%) 35 (9.5) 37 (10.1)
Socioeconomic status 0.459
 Low (332, 45.1%) 171 (46.5) 161 (43.8)
 High (404, 54.9%) 197 (53.5) 207 (56.2)
Mean CD4 count at 
baseline
947.04 944.02 0.939
CD4, cluster of differentiation 4; primary, 0–7 years of formal education; Secondary, 
8–14 years of formal education; Low socioeconomic status, 0–13; High socioeconomic 
status, >13. All numbers that do not add up to the total of 736 participants were due to 
missing data.
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and adolescents. Results revealed a statistically significant 
association between acute stress and IMDs. This association 
was found to be moderated by 5-HTTLPR-rs25531 in a haplotype-
dependent manner. Specifically, in comparison to L-A-L-A 
haplotype carriers with experience of mild acute stress, individuals 
carrying the S-A-S-A haplotypes were more likely to have an 
IMD under conditions of moderate and severe acute stress. 
We  found no evidence for a significant combined interaction 
of acute stress, chronic stress, and 5-HTTLPR-rs25531 on IMDs.
Stress represents a prevalent environmental risk factor for 
many mental disorders, including depression and anxiety (de 
Kloet et  al., 2005; Popoli et  al., 2011). Acute stress has been 
associated with the likelihood of developing IMDs among 
samples of adolescent school children and adult disaster workers 
(Fullerton et  al., 2004; O’Connor et  al., 2010; Brown et  al., 
2016). In line with previous studies, where acute stress has 
been associated with IMDs such as depression, PTSD (Fullerton 
et  al., 2004), and anxiety (Grillon et  al., 2007), we  found that 
risk for IMDs increased with increasing acute stress and was 
highest for severe acute stress. Chronic stress was found to 
significantly moderate the association between acute stress and 
IMDs. Previous studies have reported on chronic stress as a 
risk factor for IMDs (Charney and Manji, 2004; de Kloet et al., 
2005; Evans et  al., 2013; Adelman et  al., 2014; Robles et  al., 
2014; Revenson et  al., 2016). Vulnerability to IMDs by chronic 
stress (through an interaction with acute stress) could be  due 
to alterations in the functioning of the hypothalamic-pituitary-
adrenal axis that follow exposure to chronic stress (de Kloet 
et  al., 2005; Fuchs and Flïugge, 2006). In addition, chronic 
stress has been reported to affect serotonergic signaling in the 
brain (van den Buuse and Hale, 2019). As serotonergic systems 
have been implicated in threat appraisal, psychophysiological 
measures of stress response (skin conductance and startle 
reactions), and attentional bias to negative stimuli, it is possible 
that alterations in 5-HT signaling due to chronic stress may 
at least partially contribute to some of the behavioral features 
of IMDs (Pergamin-Hight et  al., 2012; Klumpp et  al., 2014; 
Klumpers et  al., 2015).
In contrast to previous findings of associations between 
5-HTTLPR and STin2 VNTR and IMDs (Battersby et  al., 1996; 
Evans et al., 2013; Gressier et al., 2013; Zhao et al., 2013; Smoller, 
2016; Wang et  al., 2016; Xiao et  al., 2019), we  found no direct 
association between any of the investigated SLC6A4 polymorphisms 
and IMDs. This may be  due to the complex nature of IMDs, 
where many genetic variants contribute to disease risk, each 
TABLE 3 | Association between tryptophan hydroxylase 2 gene rs1843809 and 
internalizing mental disorders (IMDs).
IMDs Odds ratio p > |Z| 95% confidence 
interval
rs1843809 GG Reference
rs1843809 TG 0.52 0.001 0.349–0.774
rs1843809 TT 0.54 0.005 0.355–0.832
IMDs, internalizing mental disorders.
TABLE 4 | Association between acute stress and IMDs.
Acute stress 
class
OR (IMDs) p > |Z| 95% CI p
Mild Reference
Moderate 1.1 0.687 0.758–1.523 0.001
Severe 1.9 0.001 1.298–2.651
OR, odds ratio; IMDs, internalizing mental disorders; CI, confidence interval.
TABLE 2 | Distribution of genotypes and Hardy-Weinberg equilibrium analysis 
between cases and controls for SLC6A4 [5-HTTLPR, rs25531, 5-HTTLPR-












5-HTTLPR (n = 698) 0.286 0.323 0.1916
LL 223 (62.3) 231 (67.9)
LS 115 (32.1) 94 (27.7)
SS 20 (5.6) 15 (4.4)
rs25531 (n = 685) 0.988 0.795 0.641
AA 227 (65.4) 221 (65.4)
AG 108 (31.1) 106 (31.4)
GG 12 (3.5) 11 (3.2)
5-HTTLPR-rs25531 haplotype (n = 685) 0.688 N/A N/A
L-A-L-A 130 (37.4) 136 (40.2)
L-A-L-G 76 (21.9) 82 (24.3)
L-A-S-A 79 (22.8) 71 (21.0)
L-A-S-G 2 (0.6) Absent
L-G-L-G 12 (3.5) 11 (3.3)
S-A-S-A 18 (5.2) 15 (4.4)
S-A-L-G 30 (8.6) 23 (6.8)
STin2 VNTR (n = 687) 0.203 0.090 0.440
10/10 26 (7.5) 28 (8.8)
10/12 126 (36.3) 112 (35.3)
12/12 189 (54.5) 177 (55.9)
9/9 5 (1.4) Absent




TT 105 (30.1) 113 (33.5)
TG 150 (43.0) 169 (50.2)




GG 210 (59.7) 202 (60.7)
GA 124 (35.2) 125 (37.5)




AA 90 (25.6) 84 (25.1)
AG 170 (48.4) 166 (49.7)




GG 88 (25.2) 90 (26.9)
GT 177 (50.7) 156 (46.7)
TT 84 (24.1) 88 (26.4)
5-HTTLPR, serotonin transporter linked polymorphic region; STin2 VNTR, serotonin 
transporter intron 2 variable number of tandem repeats; HWE, Hardy-Weinberg 
equilibrium; N/A, not applicable. *Value of p for association of each investigated 
polymorphism with IMDs.
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contributing a small effect (Plomin and Davis, 2009) and thus 
the effect of a few variants may not be  powerful enough to 
show significant association. Indeed, studies examining the 
contributions of 5-HTTLPR and STin2 variants have yielded 
inconsistent results, with other published work similarly failing 
to find a significant association (Munafò et  al., 2009a,b; 
Culverhouse et  al., 2018; Xiao et  al., 2019). In order to resolve 
these contradictory results, studies looking at epistatic interactions 
are required.
Based on the diathesis-stress hypothesis of neuropsychiatric 
disorders, we  postulated that the association between acute 
stress and IMDs would be  moderated by genetic 
polymorphisms, chronic stress, or a combination of genetic 
polymorphisms and chronic stress. Results revealed chronic 
stress and the 5-HTTLPR-rs25531 S-A-S-A haplotype to each 
significantly moderate the association between acute stress 
and IMDs.
The interaction between the 5-HTTLPR and stress has 
previously been investigated in gene-environment studies of 
IMDs (Karg et  al., 2011; Sharpley et  al., 2014). In contrast to 
previous studies that have reported the moderating role of 
5-HTTLPR on the association between stress and IMDs (Caspi 
et  al., 2003; Karg et  al., 2011; Conway et  al., 2014; Sharpley 
et  al., 2014), we  found no significant moderating effect of 
5-HTTLPR on the association between acute stress and IMDs. 
However, our results revealed that the combined 
5-HTTLPR-rs25531 haplotype significantly moderates the 
association between acute stress and IMDs. These results revealed 
the S-A-S-A genotype as a vulnerability factor for IMDs. 
HIV+ children who experienced moderate and severe acute 
stress and possessed the S-A-S-A haplotype were more likely 
to have an IMD, compared to HIV+ children who experienced 
mild acute stress and possessed the L-A-L-A haplotype.
Previous studies have reported the SS genotype to be  a 
risk for different IMD psychopathologies including depression 
(Zalsman et  al., 2006; Cervilla et  al., 2007; Karg et  al., 2011; 
Sharpley et  al., 2014; Haberstick et  al., 2016), anxiety 
(Armbruster et  al., 2009), and IMDs in general (Conway 
et  al., 2014). However, we  found no association between the 
SS genotype and IMDs in the present study. This observation 
could be  due to insufficient power to detect the effect of 
5-HTTLPR on the association between acute stress and IMDs 
among our study participants. Our study sample size had a 
post hoc power of greater than 80% (87.5% for the interaction 
analyses) under assumption that there was zero correlation 
of exposure between cases and controls and that the probability 
of exposure among controls was 0.5. There is, however, a 
possibility that the probability of exposure could have been 
less than 0.5 among controls, thus reducing the power in 
the present study. The association between the SS genotype 
and IMDs has been suggested to be  due to its lower 
transcriptional activity (Baca-García et  al., 2002; Hu et  al., 
2006). Future functional studies that examine the effects of 
the S-A-S-A compared to the L-A-L-A haplotype are  required 
for us to determine whether lower 5-HTT levels could be 
driving our results.
A significant association was observed between TPH2 
rs1843809 and IMDs. The functional role of TPH2 rs1843809 
TABLE 5 | Logistic regression analyses for the interaction of acute stress with 5-HTTLPR-rs25531 and chronic stress, respectively, on IMDs.
Model Variable Odds ratio p > |Z| 95% CI p
Excluding any 
polymorphism or chronic 
stress
Mild acute stress Reference 0.046a
Moderate acute stress 1.22 0.282 0.848–1.761




Mild AS*L-A-S-G 1 0.049b
Moderate AS*L-A-L-G 2.52 0.022 1.142–5.540
Moderate AS*L-A-S-A 1.60 0.235 0.736–3.497
Moderate AS*L-A-S-G 0.63 0.124 0.351–1.135
Moderate AS*L-G-L-G 0.83 0.870 0.092–7.535
Moderate AS*S-A-L-G 1.48 0.563 0.395–5.500
Moderate AS*S-A-S-A 14.83 0.030 1.294–170.010
Severe AS*L-A-L-G 3.72 0.002 1.630–8.474
Severe AS*L-A-S-A 2.82 0.013 1.248–6.350
Severe AS*L-A-S-G 1.16 0.629 0.641–2.091
Severe AS*L-G-L-G 0.85 0.872 0.121–6.010
Severe AS*S-A-L-G 1.58 0.493 0.426–5.881
Severe AS*S-A-S-A 11.95 0.011 1.755–81.331
Including chronic stress Acute stress*Chronic stress
Moderate AS*moderate CS 1.04 0.896 0.607–1.768 0.033c
Moderate AS*severe CS 1.80 0.035 1.041–3.106
Severe AS*moderate CS 0.95 0.904 0.406–2.217
Severe AS*severe CS 4.28 0.001 1.832–10.012
AS, acute stress; CS, chronic stress; Acute stress*5-HTTLPR-rs25531, interaction between acute stress and 5-HTTLPR-rs25531 genotypes on internalizing mental disorder (IMDs). 
aValue of p for association between acute stress and IMDs (the model without chronic stress/SLC6A4).
bValue of p for the likelihood-ratio test of interaction between acute stress and 5-HTTLPR-rs25531 on IMDs.
cValue of p for the likelihood-ratio test of interaction between acute stress and chronic stress on IMDs.
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is currently not known. Being an intronic variant, it is less 
likely that rs1843809 would have an effect on gene expression 
or protein structure, as introns are spliced during mRNA 
processing, although potential effects of intronic variants have 
been suggested (Kleinjan and van Heyningen, 2005). It is 
also possible that rs1843809 is in LD with a causal variant. 
For example, rs1843809 is in LD with a missense rs142055199 
SNP among the Luhya, a population that speaks the same 
Niger-Congo language as the population of the present study 
(Baganda; Countries and their Cultures, 2021). East African 
populations that speak this class of language have been found 
to be  genetically similar by principal components analysis 
on GWAS data from NeuroGAP pilot study (Unpublished 
results). The SNP rs142055199 is located in the zinc finger 
C3H1-type containing gene, which modulates interleukin-8 
(IL-8) transcription (National Center for Biotechnology 
Information, 2021c). Modulation of IL-8 would be  of interest 
since IMDs have been associated with inflammatory processes 
(Miller et  al., 2009; Musinguzi et  al., 2018; Hori and Kim, 
2019; Wang et  al., 2019). Further studies will be  needed to 
determine the mechanisms underlying the influence of this 
SNP in IMDs.
None of the investigated polymorphisms in TPH2 
moderated the association between acute stress and IMDs. 
This suggests that although TPH2 is critical in 5-HT 
biosynthesis (Walther et al., 2003; Carkaci-Salli et  al., 2006), 
genetic variants investigated in this study neither moderate 
an individual’s response to stress nor are they causal 
polymorphisms that moderate an individual’s response 
to stress.
Limitations and Recommendations
The following limitations should be  noted. We  defined IMDs 
as having any depressive disorder, anxiety disorder, or PTSD. 
As much as anxiety disorders are commonly comorbid with 
depression, the inclusion of PTSD (n  =  60) is contentious 
as it has been excluded from the anxiety disorder category 
in the Diagnostic and Statistical Manual of Mental Disorders 
– 5th edition (DSM-5) and is not widely accepted as an 
IMD (American Psychiatric Association, 2013). The inclusion 
of PTSD samples allowed us to achieve the desired statistical 
power. However, the low correlation between genetic risk 
factors for PTSD and those of depression and anxiety would 
have reduced the power to detect true significant associations 
and interactions. Future studies should endeavor to stratify 
analyses by specific IMDs although this will require larger 
samples. In addition, both acute and chronic stress indices 
were measured using a number of context-specific indicators. 
This approach was adopted because there is no locally adapted 
tool for assessing these indicators in this setting and the 
variables used to generate these indices are known stressors 
in this population. However, this tool remains to be validated. 
Moreover, we  did not control for population stratification at 
analysis. The study participants belong to the Bagandan 
population group, for which principal components analysis 
on a GWAS sample of over 4,700 individuals has shown less 
genetic variation among the Bagandan (unpublished data). 
There is, however, a possibility that some participants were 
not Bagandan, even though they could speak Luganda (the 
main language of Baganda), indicating that we  may have had 
an admixed sampled. Future studies should, therefore, control 
for population stratification, in order to circumvent confounding 
of results due to possible ancestry associated differences in 
genetic architecture. Also, due to the exploratory nature of 
the study, multiple testing corrections were not done. Correcting 
for multiple testing would have rendered the interaction 
analysis non-significant. We, therefore, acknowledge the risk 
of false positive findings in this study which have potentially 
important clinical implications and need to be  verified in 
future research.
CONCLUSION
Acute stress was found to be  associated with an increased 
risk of IMDs, and this association was found to be  moderated 
by the 5-HTTLPR-rs25531 S-A-S-A haplotype and chronic stress 
among Ugandan HIV+ children and adolescents. These results 
support the diathesis-stress model, though the mechanisms 
through which acute stress interacts with 5-HTTLPR-rs25531 
S-A-S-A haplotype to moderate the risk of IMDs need to 
be  elucidated. This will allow for interventions to be  targeted 
to at-risk individuals, an important consideration in resource 
constrained settings.
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